Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03132675
Brief Title: Tavo and Pembrolizumab in Patients With Stage III/IV Melanoma Progressing on Pembrolizumab or Nivolumab Treatment (PISCES)

First Submitted : April 24, 2017
First Submitted that Met QC Criteria : April 26, 2017
First Posted : April 28, 2017

Last Update Submitted that Met QC Criteria : July 15, 2019
Last Update Posted : July 16, 2019